职业,退休年龄和20年的认知衰退:社区中的动脉样硬化风险 神经认知研究
Albert C Liu1,2, Mehul D Patel3, Alden L Gross4
1Department of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland, USA, albertcyliu@gmail.com.
Neuroepidemiology
|February 22, 2024
概括
中年职业和退休年龄影响认知衰退. 较低的职业地位与女性的衰退有关,而早期退休与白人和黑人男性的衰退速度较慢有关.
科学领域:
- 神经科学是一个神经科学.
- 社会学 社会学 社会学
- 公共卫生 公共卫生
背景情况:
- 检查了中年职业和退休年龄与认知衰退的关联.
- 使用了社区中的动脉样硬化风险 (ARIC) 双种族队列.
研究的目的:
- 研究职业和退休时间如何影响认知轨迹.
- 分析这些协会中的种族和性别差异.
主要方法:
- 根据美国人口普查和职业地位得分 (n=14,090) 分类职业.
- 分类退休为70岁前或70岁后 (n=7,503).
- 采用通用估计方程模型来评估随时间推移的认知衰退,按种族和性别分层.
主要成果:
- 在所有群体中,低职业地位与较低的基线认知相关.
- 低地位和家庭主妇角色与白人女性的衰退速度更快,与黑人女性的衰退速度更慢有关.
- 70岁前退休与白人男性/女性和黑人男性的认知衰退速度较慢相关.
结论:
- 低职业地位与女性的认知能力下降有关,而不是男性.
- 早退休与白人参与者和黑人男性的认知衰退速度较慢有关.
- 需要进一步的研究,以了解观察到的关联的种族和性别特定原因.
相关概念视频
Cognitive Development During Adulthood
109
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
109
Aging
51
Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
51
Alzheimer's Disease: Overview
484
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
484
Dementia
113
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
113
The Effect of Aging on Tissues
2.1K
Several body functions deteriorate with age. The external signs of aging are easily identifiable. For example, the skin becomes dry, less elastic, and thins out, forming wrinkles. The skin of the face begins to appear looser due to a decrease in the levels of elastic and collagen fibers in the connective tissue. Additionally, melanin production in the hair follicle decreases with age, resulting in gray hair. Moreover, the senses of sight and hearing decline, so glasses and hearing aids may...
2.1K
Alzheimer's Disease: Treatment
189
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
189


